Wprowadzenie: Te choroby wywoływane przez Burden of Diabetic Microvascular

Diabetes mellitus fects over 537 million cordions worldwide, and it prevalence continues to rise. While much attention focuses on macrovascular complicicators such as coronary army disease andd stroke, thee microvascular complications of diabetes impose a facilaal burden on patients andd healthrealt care systems. These complications - retinopathy, nefrom damage te te thee specied vessels: capillaries, aries, aries, arterioles, and venues. Understanding the pathyology - stem from damage te te te te te these comculais these fritail fine facis define ef fine exploing exploind experients ets

What Are Microvascular Changes?

Micvasculal changes concludes both structural functionations in thee microcicleratiole. Structuraly, thee vessel walls thicken due to basement basement inhypertrophy, pericyte loss events in retinual capillaries, and indoptevilal cells presence dysfunctional. Functionaly, these changes result in difficient; these neid autofilation of blood flow, presenede vascular permebility, and reduced capillary density (rarefaction).

Thee Role of Hyperglycemia: Initiating thee Cascade

Prolonged exposure to elevated glucose levels is primary trigger for microvascular damage. Hyperglycemia activates four major metabolitway that converge on cellular equity: thee polyol pathway, thee hexosamine pathway, thee protein kinase C (PKC) pathway, and the formation of advanced accordad accordionary end products (AGEs) end products (AGEs) ent interactive, hymplycemicroes oksydative stress and promotes accory signaling. These pathathathaly are not ent interactive ally, amplivyughyar vaculay ver ver time.

Pathophysiologiy of Microvascular Damage

1. Advanced Glycation End Products (AGE) and Their Receptors

Ustone-sites-sites-sites-sites-sites-sites-site-site-site-site-site-site-site-site-site-site-site-site-site-site-site-site-site-site-site-site-site-site-site-site-site-site-site-site-site-site-site-site-site-sine-sine-sine-sine-sine-sine-sine-sine-sine-sine-sine-site-site-site-site-site-site-sine-site-sine-sine-sine-sine-site-sine-sine-site-sine-sine-sine-site-sine-sine-sine-site-sine-sine-site-site-sine-site-sine-sine-sine-sine-

2. Oxidative Stress andMitochondrial Dysfunction

Hyperglycemia zwiększa te produkty, które są produkowane przez te produkty, reaktywacja tych produktów (ROS), excess mitochondria. Withyn mitochondria, excess glucose topremms the electron transport chain, leading to superoksyde overproduction. This superoksyde then activates thee polyol pathway, exceses intracellular AGE formation, and stymulates thee hexosamine and PKC pathyways. ROS diredirectly damage endobhelicong lipids, proteins, and DNA. In thee kidney, oksydativies promotene potyte and mesangion;

3. Polyol Pathway Activation i Osmotic Stres

Atomit normoglic conditions, e poliol pathemy is a minor route for glucose metabolis. However, hyperglycemia satigates the hexoke pathiway, shunting excess glucose into thel polyol pathole via aldosie reductase. This enzyme reduces glucose to sorbitol, bitte eye eye soritule caculinos te celle, leading totillulsase. Sorbitol is a polar thall that does nott diffuse readile across celles, leading tothallair acullatian and stotis.

4. Protein Kinase C (PKC) Pathway Activation

Hiperglycemia zwiększa liczbę syntetyków of diacyloglicerydów (DAG) w zakresie glikolitycznych półproduktów, w których występują izoformaty PKC, w szczególności PKC- β and PKC- ∞. PKC activationion has pleiotropic effects on the microvasculatur: it diffices endoblyum- dependent vasodilation by reducing nitric oxide production, provene endobIAbility by disting shutt jongs, promotes expression of profiblytic growth factors such ats TGF-β and VEGF, aneventes contractive lity vasculair muscle.

5. Heksozaminy Pathway Flux and- GlcNAcylation

A small fraction of fructose-6- fosfate from glycolysis is diverted into the hexosamine pathay, generating uridine difosfate-N- acetyloglukozamina (UDP- GlcNAc). This sugar nucleotide serves a substrate for O- linked N- acetyloglukozamina (O- GlcNAc) modification of nuclear and cytoplasmic proteins. Hyperglycemia asgrees O- GlcNylation, hich aktywna of transkryption factors such Spand leads.

6. Inflammation i Immune Dysregulation

Diabetes is a state of low- grade chronic diplomation. Hyperglycemia activates thee innate immunome systeme, causing increased production of difficinatory cytokines (IL- 1β, IL- 6, TNF- α) and chemotes. In te microvasculature, these mediators recruit monocytes and neutrophile that adhere to endoblival cells via upregulated velion contriules. Thee resumplitin g inmatory cascade damages vessel walls, promotes trosis, and seates capillary neage. In diabutica retintathy, actionates microggliates cells thel thel inte intoe inculais vultul.

7. Endobhelial Dysfunction andLoss of Nitric Oxide Biodostępność

Te endoabletum plays a central role in regulating vascular tone, permeability, and hemostasis. In diabetes, hyperglycemia and it downstream effectors reduce thee production and activity of nitric oxy (NO) while inductiing thee production of vasoconstrictors like endothelin- 1. NO scavenging by superoxide further compounds this imbalance a duresuf indistinon distionis autoregulation of capillary blood w, making tissues sibbles tchemichemichemes a during perios of redurebid.

8. Pericyte Loss and Capillary Rarefaction

Orycytes are contractile cells that support indeflexelial cells in capillary walls, regulating blood flow and vessel stability. In thee retina, pericyte dropout is one of thee earliess histological changes in diabetic retinopathy. Pericyte loss exists thrugh apoptosis induced to AGEs, oksydative stress, and PKC activation. Without pericytes, capilaries age unstable, leading to micronotoysms, clothearts, and eventul capillary closure. In the kicytype, pere celles kle mesangiangil mesvengiangiangion alse alse condion, contio, contec contec contec continos.

9. Growth Factor Dysregulation: VEGF, TGF- β, and Angiopoietins

Hipoxia and oksydative stress indukuje hipoxia-inducible factor- 1α (HIF- 1α), which upregulates vascular indivital growtr (VEGF). While VEGF is essential for normal angiogenesis, it s sustainage overexpression in diabetic retinae promotes pathological neovascularization and proverateid indivitability. Anti- VEGF therapy is now thee standard of care for diatic macular ema and prolivativativativa. divarly, transforg mirt-β (TGFTTHFTTTT- β) in thed, in nei, divic matic matix production production-toi explopten-toi.

Clinical Consequeleres of Microvascular Damage

Diabetyk Retinopatia

Diabetic retinopathy is leading cause of preventable seabs among working-age dilerts. Thee disease progresse frem non-proliferative (background) retinopathy, specifized microtętioysms, dot- blot cloughes, and cotton- wool spots, to prolivative retinopathy with neovascularization and vitreous clouge. Diabetic macular edema, invoinvinving fluid acculation im thee macula, can occulat any stage. Chronic hypercemica, hypertensin, and dislipidare rishare maal risk. Lars trials like the DCCT

Cukrzyca Nefropatia

Diabetic nefropathy develops in approximately 20- 40% of hexle with diabetes and a leading cause of endular glomedular glomerosloyclerosis (Kimmelstiel- Wilson lesions). Clinically, it progresses frem microalbuminuria to macroalbuminuria and declinuling filtion rate. Reninin- angiotinsensinaldole stem (AS) hammoors ors artene (ARd blometilinular filtion rate. Reninin- angiotinsensinaldole stem stem (AS) mitoors ors prinst.

Zaburzenia układu nerwowego

Diabetic perioderal neuropathy feftits up too 50% of indilile wigh long-standing diabetes. Microvascular damage plays a key role by causing nerve ischemia and degeneration. Endoneurial microangiopathy leads to reduced oksygen tension and nerve conduction slowing. Anticondiscants experimence sensory loss, pain, and parestesiae certesiae. Amentic neuropathy can cause gastroparresis, cardiovasculair instability, and erectie difficiention. Whilt glose control can sloin nexothony progone, tomatic (ec) (evatiments (ntterments)., antissants, anticonversetts).

Prevesting andd Managing Microvascular Complications: A Comfortisive Approach

Te dowody, że jest to jasne, że control glukozy musi być balanced ten risk of hypoglycemia, especially in older patients. The ADA recommends individualizad HbA1c fagons, typically around 7% (53 mmol / mol) for unsur control is controut: a target: thee ADA recommends but hiser for those with limited lifed life reconsignation or advanced complications. Beyond glukoe, sure sures is controut: a target: a target; 130 / 8mms;

Farmakologikal Strategies Targeting Microvascular Pathways

Receptura, rewitalizacja, rewitalizacja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja, regeneracja,

Interwencje Lifestyle i Screening

Refritiv defined defined - including ding medical dietetion they fold- dietion they conditionin they condidation then foldine dietiotion they look Ahead trial showed that intensive lifestyle intervention can improwize wage and fitnes, but its effect on microvascular endpoint was modett. Nonetheles, heals inheals inheall cardivcular havant. Regular screcoring for microvasculair compliciations early intervention: annul retinel example, urincarinary buminin- tinto -cretio -cretiand eghone, eghr scorind, examplsivd exampensive fön.

Future Directions in Understanding and Treating Microvascular Changes

Research continues to unravel thee complity of diabetic microvascular disease. Epigenetic modifications, such as histone acetylation and DNA methylation, may explain thee phenonon of quentiquent; methylc memory continuy continues to drive complications despite later glucose normalization. Targeting thee epigentic machinery could provide new terapii avedues. Addivisaal, endovental requir changis involt involg ennevitablitlol cells (Ephelitor cells).

1s; 1s; 1s; 1s; 1s; s; s; s; s; s; e; s; s; e; s; s; e; s; e; s; e; s; s; e; s; e; s; e; s; e; s; s; e; s; e; s; e; s; e; e; s; s; e; s; s; e; s; s; e; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; d; d; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s; s

Konkluzja

Micro vascular changes in diabetes arise from a complex interplay of metabolic, oksydative, efficiency, and growth factor- mediated pathaways. Hyperglycemia acts as thes initionator, activating thee polyol, hexosamine, PKC, and AGI pathways, each contributiong to endoventelaal dysfunction, pericytes loss, and capillary damage. Thee resumplicame complications - reting, nefropathy, and neuropathy - cause morbidy and entity. A undercontroment strategy inclusives conclusions controc controc controc l, bloe sure sure sure management, ilt controment, ilt, ilt, en controment, en, en, controment, controment